March 28th 2024
Researchers shared details of a noninvasive technique that detects abnormal inflammatory cytokine profiles in the skin of asymptomatic infant patients who subsequently develop AD.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Post-transplant disorder a risk: Lymphoproliferative condition can be life-threatening
February 1st 2009Post-transplant lymphoproliferative disorder is lymphocyte proliferation in patients following post-transplant immunosuppression and is the most common neoplasm in pediatric organ transplant recipients. Due to the increased frequency of organ transplantation, dermatologists should be aware of the cutaneous presentation, as a timely diagnosis and treatment is crucial for a favorable prognosis.
Sinusitis connection: Chronic UAI, AD improve with surgery
February 1st 2009Results of a recent study suggest that while upper airway infections, such as rhinosinusitis and adenotonsillitis, may exacerbate atopic dermatitis in children, surgical treatment for those infections may improve the severity of AD.
The obesity factor: Researchers study psoriasis, co-morbidities
November 1st 2008Etanercept is effective in treating psoriasis in the pediatric population, a study has found. The research also found that patients in the study had increased levels of C-reactive protein, an inflammatory marker that may be elevated as a result of abdominal obesity.
Puzzling pediatric diagnoses: Kawasaki disease linked with specific genetic polymorphism
October 1st 2008Important pediatric diagnoses for consulting dermatologists include Kawasaki disease, an expert says. It recently has been linked with a specific genetic polymorphism, which suggests that uncontrolled inflammation plays a role in its etiology.
Atopic dermatitis: Emerging knowledge enhances clinical practices
October 1st 2008Recent developments in pediatric atopic dermatitis include the discovery of filaggrin gene mutations and their possible role, a new appreciation of the epidermis' role in the immune system and renewed emphasis on patient education, an expert says.
Pediatric MRSA: Multiple settings present 'breeding grounds' for disease
October 1st 2008Schools, sports programs, and day care centers provide ideal "breeding grounds" for methicillin-resistant Staphylococcus aureus infections. Any suspicious lesion should be cultured early. Comprehensive education is needed to minimize risk of transmission and to quell hysteria.
Vascular anomalies: Clinicians must treat underlying disease in children with port wine stains
July 1st 2008When children present with port wine stains, clinicians should consider serious conditions and underlying disease. Vascular anomalies can be classified into two major groups: vascular tumors, which infantile hemangiomas are the most frequent, and vascular malformations.
Commentary: Dealing with teen patients that are plugged in and tuned out
June 1st 2008Have you ever met anybody who is plugged in and tuned out? How about the acne patient who is listening to an ipod when you enter the room and continues to listen despite your greeting? How about the acne patient and their parent who are both listening to their own separate ipods and continuing to listen despite your greeting? What should you do?
Enbrel yields striking improvement in kids
May 1st 2008A phase 3 double-blind, placebo-controlled study shows remarkable efficacy of etanercept for treating pediatric psoriasis, bettering even those results observed in adults. The findings could help pave the way for Food and Drug Administration approval of the biologic, which could change the face of systemic treatment of psoriasis in children.
Pediatric psoriasis: Presentation in childhood linked to genetics
May 1st 2008Psoriasis has a stronger genetic component when it presents in childhood than when it presents in adulthood. In children, scalp involvement is very common if they present with psoriasis. In addition, presentation in childhood is correlated with a greater tendency for more severe psoriasis over one's lifetime.
What's new in psoriasis therapy
May 1st 2008Some current therapies of psoriasis, though effective, are marred by their poor safety profile. A new experimental drug, similar in molecular structure to cyclosporine, has been shown to be safe and effective in the treatment of moderate to severe chronic plaque psoriasis.
A shot in the dark: Safety, efficacy, research lacking for pediatric medications
April 1st 2008Pediatric dermatologist Elaine Siegfried, M.D., says that, about 80 percent of the time, she has to treat patients with drugs that have no FDA-approved indication or have never been formally studied in children.
Pediatric dermatology evolves with standardized fellowships, board certification
April 1st 2008Pediatric dermatology leaders are making strides toward giving their specialty the clout they believe it deserves. Not only has pediatric dermatology become a board certified subspecialty, but it now offers accredited and standardized one-year fellowships.
Lightening up: Advances, new combo laser increase options for port wine stains
April 1st 2008Modifications in existing laser technology and a combination laser can help treat various types of port-wine stains more effectively than in the past, according to Jeffrey Dover, MD,FRCPC, a dermatologist with SkinCare Physicians, of Chestnut Hill, Mass.
Pediatric psoriasis: Etanercept holds promise in younger population
April 1st 2008New research indicates that etanercept, a systemic agent, holds promise of treating moderate-to-severe psoriasis in the pediatric population and is a safe option. Clinicians currently use various off-label therapies to treat psoriasis in children and teens, including methotrexate and retinoids. One of the positive outcomes of the study was that patients did not develop a tolerance to therapy. In addition, patients who had been on placebo in the initial phase of the research did improve when they were retreated in an open-label phase of the study with etanercept. Extended follow-up of patients will establish if the therapy is safe for patients to take over the long term.
Treating teens: Self-esteem, expectations determine cosmetic procedures
April 1st 2008In the late 1990s and early 2000s, a good deal of media attention focused on the rising number of cosmetic-surgery procedures performed on teenagers. In 2004, for example, ABC News reported that plastic surgery on teens was on a significant rise-particularly breast augmentation, which ABC reported was up 24 percent.
Pediatric dermatology workforce challenge
April 1st 2008The training's tough, hours can be long, and the pay ... not usually as high as what other dermatologic subspecialists make; still, pediatric dermatologists contend that the career offers doctors challenging options in dermatology and the chance to impact children's quality of life.
Off-label treatments play potential role in management of HOIs
January 1st 2008Systemic corticosteroids ormedical intervention is indicated for hemangiomas of infancy. Recenliterature reports describe favorable experience with off-label use of imiquimod cream 5 percent (Aldara, Graceway), becaplermin gel 0.01percent (Regranex, Ortho-McNeil) and vincristine.
Nurses better at treating childhood eczema than dermatologists, study finds
November 6th 2007Melbourne, Australia - An Australian study suggests that nurses may be more effective in reducing the severity of atopic eczema in infants, children and adolescents than those treated by a dermatologist, ReutersHealth reports.
FDA advisory impacts treatment practice patterns for atopic dermatitis in babies
October 1st 2007A retrospective, longitudinal cohort study was undertaken to analyze the effects of the FDA advisory on off-label topical calcineurin inhibitor (TCI) treatment practice patterns for infants with atopic dermatitis (<2 years of age). The results show a reduction in overall utilization of AD-related medications and reduced utilization of TCIs coupled with early introduction of topical corticosteroid treatment after the advisory compared to the period preceding the advisory.